Reversal of Myoblast Aging by Tocotrienol Rich Fraction Posttreatment

Table 1

Effect of SIPS and TRF on the myogenicity of myoblasts. The young myoblasts, TRF control, and posttreatment group exhibited more than 80% myogenicity. However, the myogenic purity of the SIPS-induced group and pretreatment group were less than 80%.

Group of treatment	Myogenicity (%)
Young control	80.12±2.07
SIPS	72.27±3.67
TRF control	80.09±3.46
Pretreatment with TRF	72.84±1.21^∗
Posttreatment with TRF	82.73±4.87

^∗𝑃<0.05 compared to young control.